Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Blog
Biosimilars Council Press Releases
Blog
Blog
April 25, 2019
AAM
National Drug Take Back Day Is Saturday: Here’s What You Need to Know
Blog
April 1, 2019
AAM
NAFTA 2.0: 3 Obstacles to More Affordable Medicines in the U.S.
Blog
March 11, 2019
AAM
Talking Female Leadership at Access! 2019
Blog
February 26, 2019
AAM
Rich’s Generic Story: No Sweat
Blog
February 25, 2019
AAM
Access! New Orleans Style: An Industry Steps Up
Blog
February 20, 2019
AAM
HHS Proposal Will Help America’s Patients Realize the Full Value of Their Generics and Biosimilars
Blog
February 6, 2019
AAM
Alex Azar to Speak at Access! 2019
Blog
January 31, 2019
AAM
Thanks to Her Generic Prescriptions, Jonnie is Oklahoma O.K.
Blog
January 30, 2019
AAM
Take Our Generic Prescriptions Quiz!
Blog
January 30, 2019
AAM
From Sea to Shining Sea: Generic Savings State by State
Blog
November 29, 2018
AAM
Preliminary Recommendations for Addressing Drug Shortages
Blog
November 28, 2018
AAM
You’re Invited! AAM Strategic Priorities Planning for the New Year
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
